Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
30 janv. 2024 09h25 HE
|
Palisade Bio, Inc.
Carlsbad, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for...